The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

 

Community Health Systems Inc

NYSE: CYH
Last

(U.S.) $47.27

Today's change-0.44 -0.92%
Updated November 26 4:04 PM EST. Delayed by at least 15 minutes.
 

Community Health Systems Inc

NYSE: CYH
Last

(U.S.) $47.27

Today's change-0.44 -0.92%
Updated November 26 4:04 PM EST. Delayed by at least 15 minutes.

Community Health Systems Inc down (U.S.)$0.44

Community Health Systems Inc closed lower Wednesday, dropping (U.S.)$0.44 or 0.92% to (U.S.)$47.27. Shares have lost 0.38% over the last five days, but have gained 20.37% over the last year to date. This security has performed in-line with the S&P 500 during the last year.

Key company metrics

  • Open(U.S.) $47.96
  • Previous close(U.S.) $47.71
  • High(U.S.) $48.02
  • Low(U.S.) $46.98
  • Bid / Ask-- / --
  • YTD % change+20.37%
  • Volume1,015,272
  • Average volume (10-day)2,127,587
  • Average volume (1-month)2,417,213
  • Average volume (3-month)1,829,670
  • 52-week range(U.S.) $34.55 to (U.S.) $57.72
  • Beta1.64
  • Trailing P/E123.68×
  • P/E 1 year forward14.74×
  • Forward PEG0.80×
  • Indicated annual dividend--
  • Dividend yield0.00%
  • Trailing EPS(U.S.) $0.38
Updated November 26 4:04 PM EST. Delayed by at least 15 minutes.

Profit

Net Profit (TTM)
+0.84%

Based on its net profit margin of 0.84%, Community Health Systems Inc is less effective than other companies in its industry at turning revenues into bottom line profit.
Company Books

S&P TSX0.00%Sector:HealthcareIndustry:Healthcare Facilities
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q3/2014Q2/2014Q1/2014Q4/2013
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedSep 30, 201409/30/2014Jun 30, 201406/30/2014Mar 31, 201403/31/2014Dec 31, 201312/31/2013
Revenue4,7954,7794,1953,231
Total other revenue--------
Total revenue4,7954,7794,1953,231
Gross profit4,0624,0413,5602,719
Total cost of revenue733738635512
Total operating expense4,4244,4284,1173,016
Selling / general / administrative3,4223,4593,1262,336
Research & development--------
Depreciation / amortization280315299200
Interest expense (income), net operating--------
Unusual expense (income)7709724
Other operating expenses, total-88-84-40-56
Operating income37135178215
Interest income (expense), net non-operating--------
Gain (loss) on sale of assets--------
Other--------
Income before tax133107-13572
Income after tax9375-7852
Income tax, total4032-5720
Net income6242-11228
Total adjustments to net income--------
Net income before extra. items6147-9228
Minority interest-32-28-14-24
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items6147-9228
Inc. avail. to common incl. extra. items6242-11228
Diluted net income6242-11228
Dilution adjustment0--0--
Diluted weighted average shares11411310795
Diluted EPS excluding extraordinary itemsvalue per share0.530.41-0.860.30
Dividends per sharevalue per share0.000.000.000.00
Diluted normalized EPSvalue per share1.000.41-0.270.48